US Nuclear Corporation articles

Good News for Cancer and Heart Disease Patients: US Nuclear Partner Achieves Critical Milestone Proving New Way to Fill Multi-Billion/Year Shortage of Radioisotopes for Diagnostics and Treatments

• The National Academies of Sciences, Engineering and Medicine warns about

DENVER, CO / ACCESSWIRE / September 5, 2018 / A significant milestone has been reached in nuclear fusion by MIFTEC Laboratories, Inc. when they recently exceeded 10¹⁰ neutrons per pulse power level. This level of neutron flux is close to that which is needed to commercially produce radionuclides for nuclear medicine, and validates previous claims regarding the commercial viability of their fusion-powered device.With US Nuclear Corp. (OTC PINK: UCLE) being designate

DENVER, CO / ACCESSWIRE / July 16, 2018 / On June 22^nd a mechanical failure at the Lucas Heights nuclear reactor in Sydney, Australia shined a light on the tenuous supply chain of medical radioisotopes worldwide. These isotopes are key tools in both diagnosis and treatment for a wide range of medical conditions. The mechanical error at the Sydney plant sent hospitals throughout Australia and Southeast Asia scrambling to cover more than 10,000 doses a day, or about

The radiation detection holding company signed a letter of intent last week with MIFTEC, whose parent company is Magneto-Inertial Fusion Technologies Inc. (MIFTI) Nuclear Fusion, for the sole manufacturing rights of its generators. These utilize its Staged Z-Pinch fusion technique to produce a high number of neutrons, which can then be used to create medical isotopes. “One of the reasons that we’re so excited to be constructing this agreement is that MIFTI and MIFTEC have develope